Role of 5α-Reductase Inhibitors in Benign Prostatic Diseases
February 2012
in “
Prostate cancer and prostatic diseases
”
Studysummary 5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on nature.com →